Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_assertion type Assertion NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_head.
- NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_assertion description "[INSL3 rs10421916 and rs11088680 had both a 0.8-fold decreased OR for gastric cancer (95% CIs = 0.7-0.97; and 0.7-0.9, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_provenance.
- NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_assertion evidence source_evidence_literature NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_provenance.
- NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_assertion SIO_000772 23028900 NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_provenance.
- NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_assertion wasDerivedFrom befree-20150227 NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_provenance.
- NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_assertion wasGeneratedBy ECO_0000203 NP513478.RA_nVXPSklqXYAQXMU7c9A_yLuc8v565Cq7acO45TlwZw130_provenance.